Cantor Fitzgerald Reiterates Overweight on Zevra Therapeutics

BenzingaOct 1 20:35

H.C. Wainwright Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Raises Target Price to $20

Futu NewsSep 30 18:31 · Ratings

Zevra Therapeutics Analyst Ratings

BenzingaSep 30 18:26 · Ratings

Zevra Therapeutics, Inc. (NASDAQ:ZVRA): Is Breakeven Near?

Simply Wall StSep 28 21:11

Maxim Group Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Raises Target Price to $25

Futu NewsSep 25 19:31 · Ratings

Investors in Zevra Therapeutics (NASDAQ:ZVRA) Have Seen Decent Returns of 67% Over the Past Year

Yahoo FinanceSep 25 18:43